Stockreport

Arcutis Biotherapeutics Inc (ARQT) Q3 2024 Earnings Call Highlights: Robust Growth and ... [Yahoo! Finance]

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF New Prescription Growth: Increased 23% quarter over quarter. Gross to Net Improvements: Improved to the low 50% range from the high 50s last quarter. Net Product Re [Read more]